{"id":417485,"date":"2022-01-14T16:29:15","date_gmt":"2022-01-14T16:29:15","guid":{"rendered":"https:\/\/www.finder.com\/uk\/?page_id=417485"},"modified":"2025-04-15T09:28:51","modified_gmt":"2025-04-15T08:28:51","slug":"pharmaceutics","status":"publish","type":"post","link":"https:\/\/www.finder.com\/uk\/share-trading\/invest-in\/health-stocks\/pharmaceutics","title":{"rendered":"Invest in pharmaceutical stocks"},"content":{"rendered":"

In the Covid pandemic, pharmaceutical (pharma) companies have made headlines in their efforts to get the world back up and running with effective vaccines to the virus. The speed and success at which AstraZeneca<\/a> and Pfizer<\/a> both got vaccines to market shows that despite having a reputation for being high risk, pharma companies can be compelling for long-term investors<\/a>. <\/p>

This is because the possibility of patented entry into new areas of treatment means pharma companies can present profitable opportunities for those who do their research.<\/p>\n\n\n\n